Drug discovery technology encompasses a range of techniques and strategies employed in the identification of new drugs and the recognition of chemical entities with potential therapeutic applications. These methodologies are geared towards pinpointing and developing potential drug candidates for the treatment of various diseases.
The primary categories of drug discovery technologies include high-throughput screening, genomics, nanotechnology, bioinformatics, combinational chemistry, pharmacogenomics, biochips, bioanalytical instruments, and ribonucleic acid interface (RNAI). High-throughput screening is a method designed to rapidly assess the biological activity of numerous samples, expediting the drug discovery process. These technologies find application in the discovery of drug types such as small molecule drugs and biologic drugs, addressing conditions such as cancer, immunological disorders, neurological ailments, cardiovascular diseases, and others. Pharmaceutical companies, biopharmaceutical companies, biotechnology firms, research institutes, and other entities utilize these technologies for drug discovery purposes.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The drug discovery technologies research report is one of a series of new reports from The Business Research Company that provides drug discovery technologies market statistics, including the drug discovery technologies global market size, regional shares, competitors with a drug discovery technologies market share, detailed drug discovery technologies market segments, market trends and opportunities, and any further data you may need to thrive in the drug discovery technologies. This drug discovery technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The drug discovery technologies market size has grown rapidly in recent years. It will grow from $72.99 billion in 2024 to $80.76 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to growth in genomic and proteomic research, increased understanding of molecular biology, expansion of combinatorial chemistry, adoption of bioinformatics and computational approaches, rise of targeted therapies.
The drug discovery technologies market size is expected to see rapid growth in the next few years. It will grow to $124.89 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to adoption of crispr for gene editing, expansion of precision medicine approaches, application of omics technologies in drug development, utilization of quantum computing in drug discovery, rise of patient-derived xenograft (pdx) models. Major trends in the forecast period include advancements in high-throughput screening, development of automated laboratory equipment, collaboration between academic and industry research, technological advances in imaging and microscopy, integration of artificial intelligence in drug discovery, 3d cell culture technologies, adoption of machine learning in drug design, collaboration between pharma companies and tech startups, integration of blockchain for data security.
The forecast of 11.5% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. research institutions by raising prices of AI-based molecular modeling software and robotic assay systems developed in Israel and France, potentially delaying scientific breakthroughs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated increase in the prevalence of acute and chronic diseases is poised to drive the drug discovery technologies market in the future. Chronic diseases, which persist for a year or more and necessitate ongoing medical attention, have witnessed numerous innovative treatments through advancements in drug discovery technologies and drug development. The incorporation of emerging technologies such as digital health tools, artificial intelligence (AI), and machine learning in the drug research and development (R&D) process presents opportunities to overcome critical barriers and streamline clinical trials for prevalent chronic diseases. As of May 2023, according to The United Nations (UN), chronic diseases accounted for seven out of 10 deaths in the US, resulting in over 1.7 million annual fatalities. Hence, the escalating prevalence of acute and chronic diseases is expected to be a driving force for the drug discovery technologies market.
The increase in healthcare expenditures is anticipated to propel the growth of the drug discovery technologies market. Healthcare expenditures encompass all costs associated with providing health services, family planning activities, nutrition programs, and emergency assistance with a focus on health. A surge in healthcare spending supports research and development, fostering the expansion of drug discovery technologies through the funding of advanced technologies and infrastructure. For instance, in December 2023, as reported by the Centers for Medicare & Medicaid Services, US healthcare spending witnessed a 4.1% increase in 2022, reaching $4.5 trillion, or $13,493 per person, constituting 17.3% of the country's gross domestic product. Consequently, the rise in healthcare expenditures is a significant driver for the growth of the drug discovery technologies market.
The emergence of advanced technologies stands out as a prominent trend in the drug discovery technologies market. Major companies in this sector are actively introducing sophisticated technologies to maintain their market positions. In May 2023, Google LLC, a US-based technology company, unveiled the Target and Lead Identification Suite-an AI-based tool designed to expedite drug discovery. This tool aids businesses in anticipating and understanding protein structure, a critical element in drug research, by assisting researchers in ingesting, storing, analyzing, and sharing vast volumes of genetic data. The Suite is anticipated to save considerable time and money in the drug development process, addressing a longstanding challenge in the biopharmaceutical sector.
Major companies operating in the drug discovery technologies market are concentrating on advanced solutions, such as drug research and development platforms, to enhance precision in high-throughput analysis. A drug research and development platform serve as a systematic framework for discovering, designing, testing, and bringing pharmaceutical compounds to market. For example, in July 2023, Dotmatics Inc., a US-based scientific software company focused on research and development, launched the Small Molecule Drug Discovery Solution. This comprehensive platform, equipped with pre-configured workflows and enhanced data management features, aims to foster collaboration, boost productivity, streamline operations, and expedite the transformation of data into actionable insights. This advancement accelerates the development of life-enhancing drug therapies by providing researchers with targeted capabilities and templates for a cohesive workspace spanning hit discovery to lead optimization research.
In June 2024, Simulations Plus, Inc., a US-based software company, acquired Pro-ficiency Holdings, Inc. for $100 million. This acquisition allows Simulations Plus to broaden its drug discovery and development capabilities, improving clinical trial operations, commercialization efforts, and data analytics, while also unlocking considerable market growth potential. Pro-ficiency Holdings Inc. is a US-based company that offers simulation-based learning, intelligence, and compliance solutions for life sciences, including technologies for drug discovery.
Major companies operating in the drug discovery technologies market include F. Hoffmann-La Roche AG, Novartis AG, Thermo Fisher Scientific Inc., AstraZeneca plc., Merck KGaA, GE HealthCare Technologies Inc., Agilent Technologies Inc., Dassault Systemes SA, Charles River Laboratories International Inc., Bio-Rad Laboratories Inc., Evotec SE, Curia Global Inc., Aragen Life Sciences Private Limited, Luminex Corporation, BioXcel Therapeutics Inc., Certara Inc., Schrodinger Inc., Sygnature Discovery Ltd., Recursion Pharmaceuticals Inc., InSilico Medicine Inc., ChemAxon Ltd., Enamine Ltd., BenevolentAI Limited, OpenEye Scientific Software Inc., Collaborative Drug Discovery Inc., Pharmacelera S.L., Gyros Protein Technologies AB, Optibrium Ltd., Cresset Group, Relay Therapeutics Inc.
North America was the largest region in the drug discovery technologies market in 2024. The regions covered in the drug discovery technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the drug discovery technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The drug discovery technologies market consists of revenues earned by entities by drug screening, predictive analytics, modeling, simulation, and computational capabilities. The market value includes the value of related goods sold by the service provider or included within the service offering. The drug discovery technologies market also includes sales of automation tools, computational chemistry software, imaging software, and mass spectrometers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Drug Discovery Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on drug discovery technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for drug discovery technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drug discovery technologies market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Technology: High Throughput Screening; Genomics; Nanotechnology; Bioinformatics; Combinational Chemistry; Pharmacogenomics; Biochips; Bioanalytical Instruments; Ribonucleic Acid Interface (RNAI)
- 2) By Drug Type: Small Molecule Drugs; Biologic Drugs
- 3) By Disease Application: Cancer Diseases; Immunological Diseases; Neurological Diseases; Cardiovascular Diseases; Other Disease Applications
- 4) By End-User: Pharmaceutical Companies; Biopharmaceutical Companies; Biotechnology Companies; Research Institutes; Other End-Users
- Subsegments:
- 1) By High Throughput Screening: Automated Screening Systems; Assay Development
- 2) By Genomics: DNA Sequencing; Genomic Data Analysis
- 3) By Nanotechnology: Nanoparticle-Based Drug Delivery; Nanomaterials For Drug Formulation
- 4) By Bioinformatics: Data Analysis Tools; Computational Biology Software
- 5) By Combinational Chemistry: Library Synthesis Techniques; Screening Methods
- 6) By Pharmacogenomics: Genetic Testing Platforms; Personalized Medicine Applications
- 7) By Biochips: Microarrays; Lab-On-A-Chip Technologies
- 8) By Bioanalytical Instruments: Mass Spectrometry; Chromatography Systems
- 9) By Ribonucleic Acid Interface (RNAI): RNA Interference Technologies; Therapeutic RNA Applications
- Companies Mentioned: F. Hoffmann-La Roche AG; Novartis AG; Thermo Fisher Scientific Inc.; AstraZeneca plc.; Merck KGaA; GE HealthCare Technologies Inc.; Agilent Technologies Inc.; Dassault Systemes SA; Charles River Laboratories International Inc.; Bio-Rad Laboratories Inc.; Evotec SE; Curia Global Inc.; Aragen Life Sciences Private Limited; Luminex Corporation; BioXcel Therapeutics Inc.; Certara Inc.; Schrodinger Inc.; Sygnature Discovery Ltd.; Recursion Pharmaceuticals Inc.; InSilico Medicine Inc.; ChemAxon Ltd.; Enamine Ltd.; BenevolentAI Limited; OpenEye Scientific Software Inc.; Collaborative Drug Discovery Inc.; Pharmacelera S.L.; Gyros Protein Technologies AB; Optibrium Ltd.; Cresset Group; Relay Therapeutics Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Drug Discovery Technologies Market Characteristics
3. Drug Discovery Technologies Market Trends And Strategies
4. Drug Discovery Technologies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Drug Discovery Technologies Growth Analysis And Strategic Analysis Framework
- 5.1. Global Drug Discovery Technologies PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Drug Discovery Technologies Market Growth Rate Analysis
- 5.4. Global Drug Discovery Technologies Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Drug Discovery Technologies Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Drug Discovery Technologies Total Addressable Market (TAM)
6. Drug Discovery Technologies Market Segmentation
- 6.1. Global Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- High Throughput Screening
- Genomics
- Nanotechnology
- Bioinformatics
- Combinational Chemistry
- Pharmacogenomics
- Biochips
- Bioanalytical Instruments
- Ribonucleic Acid Interface (RNAI)
- 6.2. Global Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Small Molecule Drugs
- Biologic Drugs
- 6.3. Global Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Cancer Diseases
- Immunological Diseases
- Neurological Diseases
- Cardiovascular Diseases
- Other Disease Applications
- 6.4. Global Drug Discovery Technologies Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Biotechnology Companies
- Research Institutes
- Other End-Users
- 6.5. Global Drug Discovery Technologies Market, Sub-Segmentation Of High Throughput Screening, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Automated Screening Systems
- Assay Development
- 6.6. Global Drug Discovery Technologies Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- DNA Sequencing
- Genomic Data Analysis
- 6.7. Global Drug Discovery Technologies Market, Sub-Segmentation Of Nanotechnology, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Nanoparticle-Based Drug Delivery
- Nanomaterials For Drug Formulation
- 6.8. Global Drug Discovery Technologies Market, Sub-Segmentation Of Bioinformatics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Data Analysis Tools
- Computational Biology Software
- 6.9. Global Drug Discovery Technologies Market, Sub-Segmentation Of Combinational Chemistry, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Library Synthesis Techniques
- Screening Methods
- 6.10. Global Drug Discovery Technologies Market, Sub-Segmentation Of Pharmacogenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Genetic Testing Platforms
- Personalized Medicine Applications
- 6.11. Global Drug Discovery Technologies Market, Sub-Segmentation Of Biochips, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Microarrays
- Lab-On-A-Chip Technologies
- 6.12. Global Drug Discovery Technologies Market, Sub-Segmentation Of Bioanalytical Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Mass Spectrometry
- Chromatography Systems
- 6.13. Global Drug Discovery Technologies Market, Sub-Segmentation Of Ribonucleic Acid Interface (RNAI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- RNA Interference Technologies
- Therapeutic RNA Applications
7. Drug Discovery Technologies Market Regional And Country Analysis
- 7.1. Global Drug Discovery Technologies Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Drug Discovery Technologies Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Drug Discovery Technologies Market
- 8.1. Asia-Pacific Drug Discovery Technologies Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Drug Discovery Technologies Market
- 9.1. China Drug Discovery Technologies Market Overview
- 9.2. China Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Drug Discovery Technologies Market
- 10.1. India Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Drug Discovery Technologies Market
- 11.1. Japan Drug Discovery Technologies Market Overview
- 11.2. Japan Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Drug Discovery Technologies Market
- 12.1. Australia Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Drug Discovery Technologies Market
- 13.1. Indonesia Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Drug Discovery Technologies Market
- 14.1. South Korea Drug Discovery Technologies Market Overview
- 14.2. South Korea Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Drug Discovery Technologies Market
- 15.1. Western Europe Drug Discovery Technologies Market Overview
- 15.2. Western Europe Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Drug Discovery Technologies Market
- 16.1. UK Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Drug Discovery Technologies Market
- 17.1. Germany Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Drug Discovery Technologies Market
- 18.1. France Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Drug Discovery Technologies Market
- 19.1. Italy Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Drug Discovery Technologies Market
- 20.1. Spain Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Drug Discovery Technologies Market
- 21.1. Eastern Europe Drug Discovery Technologies Market Overview
- 21.2. Eastern Europe Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Drug Discovery Technologies Market
- 22.1. Russia Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Drug Discovery Technologies Market
- 23.1. North America Drug Discovery Technologies Market Overview
- 23.2. North America Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Drug Discovery Technologies Market
- 24.1. USA Drug Discovery Technologies Market Overview
- 24.2. USA Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Drug Discovery Technologies Market
- 25.1. Canada Drug Discovery Technologies Market Overview
- 25.2. Canada Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Drug Discovery Technologies Market
- 26.1. South America Drug Discovery Technologies Market Overview
- 26.2. South America Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Drug Discovery Technologies Market
- 27.1. Brazil Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Drug Discovery Technologies Market
- 28.1. Middle East Drug Discovery Technologies Market Overview
- 28.2. Middle East Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Drug Discovery Technologies Market
- 29.1. Africa Drug Discovery Technologies Market Overview
- 29.2. Africa Drug Discovery Technologies Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Drug Discovery Technologies Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Drug Discovery Technologies Market, Segmentation By Disease Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Drug Discovery Technologies Market Competitive Landscape And Company Profiles
- 30.1. Drug Discovery Technologies Market Competitive Landscape
- 30.2. Drug Discovery Technologies Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
31. Drug Discovery Technologies Market Other Major And Innovative Companies
- 31.1. GE HealthCare Technologies Inc.
- 31.2. Agilent Technologies Inc.
- 31.3. Dassault Systemes SA
- 31.4. Charles River Laboratories International Inc.
- 31.5. Bio-Rad Laboratories Inc.
- 31.6. Evotec SE
- 31.7. Curia Global Inc.
- 31.8. Aragen Life Sciences Private Limited
- 31.9. Luminex Corporation
- 31.10. BioXcel Therapeutics Inc.
- 31.11. Certara Inc.
- 31.12. Schrodinger Inc.
- 31.13. Sygnature Discovery Ltd.
- 31.14. Recursion Pharmaceuticals Inc.
- 31.15. InSilico Medicine Inc.
32. Global Drug Discovery Technologies Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Drug Discovery Technologies Market
34. Recent Developments In The Drug Discovery Technologies Market
35. Drug Discovery Technologies Market High Potential Countries, Segments and Strategies
- 35.1 Drug Discovery Technologies Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Drug Discovery Technologies Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Drug Discovery Technologies Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
